These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3487392)

  • 1. Stabilization of AD-1590, a non-steroidal antiinflammatory agent, in suppository bases by beta-cyclodextrin complexation.
    Takahashi T; Kagami I; Kitamura K; Nakanishi Y; Imasato Y
    Chem Pharm Bull (Tokyo); 1986 Apr; 34(4):1770-4. PubMed ID: 3487392
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppositories containing beta-cyclodextrin complexes. Part 1: Stability studies.
    Szente L; Apostol I; Szejtli J
    Pharmazie; 1984 Oct; 39(10):697-9. PubMed ID: 6522449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The release of naproxen in fatty suppository bases by beta-cyclodextrin complexation.
    Celebi N; Iscanoglu M; Degim T
    Pharmazie; 1991 Dec; 46(12):863-5. PubMed ID: 1818322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stabilization and reduction of irritant taste of anti-inflammatory drug pirprofen by beta-cyclodextrin complexation].
    Hibi T; Tatsumi M; Hanabusa M; Higuchi R; Imai T; Otagiri M; Uekama K
    Yakugaku Zasshi; 1984 Sep; 104(9):990-6. PubMed ID: 6335527
    [No Abstract]   [Full Text] [Related]  

  • 5. Control of NSAID dissolution by beta-cyclodextrin complexation.
    Zecchi V; Orienti I; Fini A
    Pharm Acta Helv; 1988; 63(11):299-302. PubMed ID: 3237722
    [No Abstract]   [Full Text] [Related]  

  • 6. Availability of NSAIDH beta-cyclodextrin inclusion complexes.
    Orienti I; Cavallari C; Zecchi V; Fini A
    Arch Pharm (Weinheim); 1989 Apr; 322(4):207-11. PubMed ID: 2751410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stabilization of chlorobutanol with beta-cyclodextrin in suppositories].
    Gyulai M; Apostol I
    Acta Pharm Hung; 1986 May; 56(3):125-8. PubMed ID: 3739724
    [No Abstract]   [Full Text] [Related]  

  • 8. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Ranpise NS; Kulkarni NS; Mair PD; Ranade AN
    Pharm Dev Technol; 2010; 15(1):64-70. PubMed ID: 19505225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of amorphous indomethacin from aqueous 2,6-di-O-methyl-beta-cyclodextrin solution.
    Iohara D; Hirayama F; Ishiguro T; Arima H; Uekama K
    Int J Pharm; 2008 Apr; 354(1-2):70-6. PubMed ID: 18093762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppositories containing cyclodextrin complexes. Part 2: Dissolution and absorption studies.
    Szente L; Apostol I; Gerlóczy A; Szejtli J
    Pharmazie; 1985 Jun; 40(6):406-7. PubMed ID: 4034649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bupivacaine hydrochloride complexation with some alpha- and beta-cyclodextrins studied by potentiometry with membrane electrodes.
    Kopecký F; Vojteková M; Kaclík P; Demko M; Bieliková Z
    J Pharm Pharmacol; 2004 May; 56(5):581-7. PubMed ID: 15142334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of fulvic acid and hydroxy propyl-beta-cyclodextrin on aspirin degradation.
    Anwer MK; Agarwal SP; Ali A; Sultana Y
    Drug Dev Ind Pharm; 2010 Apr; 36(4):428-30. PubMed ID: 19740038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Density functional calculations on meloxicam-beta-cyclodextrin inclusion complexes.
    Snor W; Liedl E; Weiss-Greiler P; Viernstein H; Wolschann P
    Int J Pharm; 2009 Nov; 381(2):146-52. PubMed ID: 19446616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meloxicam complexation with beta-cyclodextrin: influence on the anti-inflammatory and ulcerogenic activity.
    Baboota S; Agarwal SP
    Pharmazie; 2003 Jan; 58(1):73-4. PubMed ID: 12622261
    [No Abstract]   [Full Text] [Related]  

  • 15. Formulation of indomethacin eye drops via complexation with cyclodextrins.
    Halim Mohamed MA; Mahmoud AA
    Curr Eye Res; 2011 Mar; 36(3):208-16. PubMed ID: 21275515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of drug loading onto ion exchange resin by cyclodextrin inclusion complex.
    Samprasit W; Rojanarata T; Akkaramongkolporn P; Ngawhirunpat T; Sila-on W; Opanasopit P
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1672-80. PubMed ID: 23078590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion mode of flurbiprofen with beta-cyclodextrin and heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin, and improvements of some pharmaceutical properties of flurbiprofen by complexation.
    Imai T; Otagiri M; Saitô H; Uekama K
    Chem Pharm Bull (Tokyo); 1988 Jan; 36(1):354-9. PubMed ID: 3378297
    [No Abstract]   [Full Text] [Related]  

  • 18. Improvement of stability and dissolution of prostaglandin E1 by maltosyl-beta-cyclodextrin in lyophilized formulation.
    Yamamoto M; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):747-51. PubMed ID: 1611688
    [No Abstract]   [Full Text] [Related]  

  • 19. Enantioseparation of nonsteroidal anti-inflammatory drugs by capillary electrophoresis using mixtures of anionic and uncharged beta-cyclodextrins as chiral additives.
    Fillet M; Hubert P; Crommen J
    Electrophoresis; 1997 Jun; 18(6):1013-8. PubMed ID: 9221892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclusion complex effect on the bioavailability of clotrimazole from poloxamer-based solid suppository.
    Balakrishnan P; Song CK; Cho HJ; Yang SG; Kim DD; Yong CS; Choi HG
    Arch Pharm Res; 2012 Jul; 35(7):1169-75. PubMed ID: 22864739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.